PCN153 Physicians’ Perceptions and Use of IDH1/2 Mutational Testing and Treatment Selection among Patients with Relapsed or Refractory Acute Myeloid Leukemia in Routine Clinical Practice
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.245
https://www.valueinhealthjournal.com/article/S1098-3015(21)00462-9/fulltext
Title :
PCN153 Physicians’ Perceptions and Use of IDH1/2 Mutational Testing and Treatment Selection among Patients with Relapsed or Refractory Acute Myeloid Leukemia in Routine Clinical Practice
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00462-9&doi=10.1016/j.jval.2021.04.245
First page :
Section Title :
Open access? :
No
Section Order :
10817